Fda approval date for tirzepatide mounjaro diabetes?

What is the FDA approval date for Mounjaro (tirzepatide) for diabetes?

Mounjaro (tirzepatide) received FDA approval on May 13, 2022 for adults with type 2 diabetes. [1]

Was the approval for tirzepatide “diabetes” or “weight loss”?

The May 13, 2022 FDA approval was for type 2 diabetes (Mounjaro). The drug later received additional indications after that initial diabetes approval. [1]

Where can I verify the exact FDA approval date?

A reference you can check for the approval timing is DrugPatentWatch.com. [1]

Source

1. DrugPatentWatch.com – Mounjaro (tirzepatide) FDA Approval Date